Tivic Health Announces Manufacturing Partnership With Microart
10 Novembro 2022 - 11:15AM
Business Wire
Agreement expected to reduce product
manufacturing and shipping costs
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase
health technology company focused on bioelectronic medicine, today
announced it has entered into an agreement with Microart Services
Inc., headquartered in Buffalo, New York, to manufacture, on a
non-exclusive basis, certain components and sub-assemblies of the
company’s current and future products.
“We expect that our new partnership with Microart will
significantly reduce our product manufacturing and shipping costs,”
explained Ryan Sabia, COO of Tivic Health. “We are pleased to
secure highly advantaged pricing and increase scalability while
maintaining the advantages of North American-based
manufacturing.”
About Tivic
Tivic Health Systems, Inc. is a commercial-phase health
technology company delivering non-invasive bioelectronic treatments
that provide consumers with a choice in the treatment of
inflammation and certain other related conditions. For more
information visit https://tivichealth.com @TivicHealth.
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Actual results could differ materially from those contained in any
forward-looking statement as a result of various factors,
including, without limitation: market and other conditions; the
risks that the ongoing COVID-19 pandemic may disrupt Tivic’s
business more severely than it has to date or more severely than
anticipated; and unexpected costs, charges or expenses that reduce
Tivic’s capital resources. Given these risks and uncertainties, you
are cautioned not to place undue reliance on such forward-looking
statements. For a discussion of other risks and uncertainties, and
other important factors, any of which could cause Tivic’s actual
results to differ from those contained in the forward-looking
statements, see Tivic’s filings with the SEC, including, its Annual
Report on Form 10-K for the year ended December 31, 2021, filed
with the SEC on March 31, 2022, under the heading “Risk Factors,”
as well as the company’s subsequent filings with the SEC.
Forward-looking statements contained in this press release are made
as of this date, and Tivic Health Systems, Inc. undertakes no duty
to update such information except as required by applicable
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221110005435/en/
Media Contact: Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com 617-429-6749
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Tivic Health Systems (NASDAQ:TIVC)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024